Pay in 4 interest-free payments of $5.41 Learn more
Ships within 48 hours · Estimated delivery Aug 23 - Aug 28
This test ($298) identifies whether your non-response stems from receptor sensitivity issues, appetite-signaling dysfunction, or metabolic rate constraints
Nature 612 , 720724 (2022)
Other GLP-1 receptor agonists such as liraglutide 3mg (Saxenda) or tirzepatide (Mounjaro, per NICE TA1026) may be considered according to local commissioning arrangements and NICE guidance
Without coverage, Zepbound's list price is ~$1,086/month, though TrumpRx.gov (~$346/mo) and LillyDirect ($299-449/mo) offer lower self-pay options
Read More Corxel-Vincentages oral GLP-1 meets phase II obesity endpoints Corxel Pharmaceuticals Ltd.s oral small-molecule GLP-1 receptor agonist, CX-11, met the primary endpoints in a phase II trial evaluating the candidate in obese and overweight patients in the U.S., according to top-line results
US$ 28.68
US$ 29.81
US$ 24.29
US$ 24.45
US$ 28.12
US$ 22.47
